Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925

BACKGROUND: The major limitation to the success of chemotherapy in osteosarcoma is the development of multidrug resistance (MDR). Preventing the emergence of MDR during chemotherapy treatment has been a high priority of clinical and investigational oncology, but it remains an elusive goal. The NSC23...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yang, X, Yang, P, Shen, J, Osaka, E, Choy, E, Cote, G, Harmon, D, Zhang, Z, Mankin, H, Hornicek, F J, Duan, Z
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Translational Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056062/
https://ncbi.nlm.nih.gov/pubmed/24853187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.254
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki